ZA937164B - Delivery system - Google Patents
Delivery systemInfo
- Publication number
- ZA937164B ZA937164B ZA937164A ZA937164A ZA937164B ZA 937164 B ZA937164 B ZA 937164B ZA 937164 A ZA937164 A ZA 937164A ZA 937164 A ZA937164 A ZA 937164A ZA 937164 B ZA937164 B ZA 937164B
- Authority
- ZA
- South Africa
- Prior art keywords
- delivery system
- delivery
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20123—Virus like particles [VLP]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL497492 | 1992-09-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA937164B true ZA937164B (en) | 1994-05-23 |
Family
ID=3776443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA937164A ZA937164B (en) | 1992-09-28 | 1993-09-27 | Delivery system |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0672153A4 (xx) |
JP (1) | JPH08501453A (xx) |
IL (1) | IL107139A0 (xx) |
WO (1) | WO1994008022A1 (xx) |
ZA (1) | ZA937164B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2210273T5 (es) * | 1994-07-18 | 2010-03-29 | Conzelmann, Karl-Klaus, Prof. Dr. | Virus con arn de cadena negativa no segmentado recombinante infeccioso. |
DE19503082A1 (de) * | 1995-02-01 | 1996-08-08 | Univ Ludwigs Albert | Gegenstand und Verfahren zur bevorzugt transienten Expression und möglichen Translation spezifischer RNA im cytoplasmatischen Bereich höherer eukaryontischer Zellen |
JPH11512609A (ja) | 1995-09-27 | 1999-11-02 | アメリカ合衆国 | クローン化されたヌクレオチド配列からの感染性RSウイルス(respiratory syncytial virus)の生産 |
KR100754091B1 (ko) * | 1995-10-31 | 2007-08-31 | 가부시끼가이샤 디나벡 겡뀨쇼 | 자율 복제 능력을 갖는 (-)쇄 rna 바이러스 벡터 |
EP0863202B1 (en) | 1995-11-01 | 2010-06-09 | Dnavec Research Inc. | Recombinant sendai virus |
CA2253595A1 (en) * | 1996-05-01 | 1997-11-06 | The Government Of The United States Of America, Represented By The Secre Tary, Department Of Health And Human Services | Generation of viral transfectants using recombinant dna-derived nucleocapsid proteins |
US6818209B1 (en) | 1998-05-22 | 2004-11-16 | Oxford Biomedica (Uk) Limited | Retroviral delivery system |
AU7350798A (en) * | 1997-04-29 | 1998-11-24 | Universiteit Utrecht | Corona virus-like particles as tools for vaccination and therapy |
KR20010074493A (ko) * | 1998-05-22 | 2001-08-04 | 찰스 굿맨 | 레트로바이러스 전달 시스템 |
WO2002098457A2 (en) * | 2001-01-17 | 2002-12-12 | Thomas Jefferson University | Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
GB0119852D0 (en) | 2001-08-15 | 2001-10-10 | Univ York | Baculovirus |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7007491A (en) * | 1990-02-02 | 1991-08-08 | Schweiz. Serum- & Impfinstitut Bern | Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
CA2113572A1 (en) * | 1991-07-17 | 1993-02-04 | Peter J. Walker | Improved vaccine |
AU2366592A (en) * | 1991-07-17 | 1993-02-23 | Commonwealth Scientific And Industrial Research Organisation | Improved vaccine |
-
1993
- 1993-09-27 ZA ZA937164A patent/ZA937164B/xx unknown
- 1993-09-28 WO PCT/AU1993/000495 patent/WO1994008022A1/en not_active Application Discontinuation
- 1993-09-28 EP EP93921748A patent/EP0672153A4/en not_active Withdrawn
- 1993-09-28 JP JP6508518A patent/JPH08501453A/ja active Pending
- 1993-09-28 IL IL107139A patent/IL107139A0/xx unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08501453A (ja) | 1996-02-20 |
EP0672153A1 (en) | 1995-09-20 |
WO1994008022A1 (en) | 1994-04-14 |
IL107139A0 (xx) | 1993-12-28 |
EP0672153A4 (en) | 1997-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU3050892A (en) | Delivery system | |
GB9224191D0 (en) | Cosmetic delivery system | |
GB9414501D0 (en) | Priming system | |
ZA925275B (en) | Cosmetic delivery system | |
EP0802788A4 (en) | NEW THERAPEUTIC DELIVERY SYSTEM | |
GB9205344D0 (en) | System | |
ZA925276B (en) | Cosmetic delivery system | |
ZA937164B (en) | Delivery system | |
GB9205342D0 (en) | System | |
GB9104226D0 (en) | Liquid delivery system | |
GB9325330D0 (en) | Fluorocyclodextrin drug delivery system | |
GB9307386D0 (en) | Injector system | |
GB2292887B (en) | Drug delivery system | |
GB2272196B (en) | Distribution system | |
GB9424451D0 (en) | Syringe system | |
GB9208925D0 (en) | System | |
GB9206683D0 (en) | Glazin system | |
KR0116230Y1 (en) | Keyphone system | |
GB9026167D0 (en) | Euroside delivery system | |
AU4791096A (en) | Delivery system | |
GB9219523D0 (en) | Oral delivery system | |
GB9221151D0 (en) | Location system | |
GB9221533D0 (en) | Location system | |
GB9212955D0 (en) | Microbe delivery system | |
GB9212784D0 (en) | Auto-checkout system |